Diarrheal diseases remain a leading killer for children under 5, adults 70+byInstitute for Health Metrics and EvaluationCredit: Unsplash/CC0 Public DomainA global study reports a 60% drop in glo
Diarrheal diseases remain a leading killer for children under 5, adults 70+byInstitute for Health Metrics and EvaluationCredit: Unsplash/CC0 Public DomainA global study reports a 60% drop in glo
Diarrheagenic E. coli (DEC) is one of the major pathogens causing diarrheal diseases globally. Some strains of DEC exhibit alarmingly high levels of antibiotic resistance.
Diarrheagenic E. coli (DEC) is one of the major pathogens causing diarrheal diseases globally. Some strains of DEC exhibit alarmingly high levels of antibiotic resistance.
The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert® MTB/RIF Ultra. This is the first test for TB diagnosis and antibiotic susceptibility testing that meets WHO's prequalific
The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert® MTB/RIF Ultra. This is the first test for TB diagnosis and antibiotic susceptibility testing that meets WHO's prequalific
by Jenny Ryltenius,Karolinska InstitutetCredit: CC0 Public DomainWhen you hear the words mucus and snot, you might think of colds, snails or drooling babies. But the runny, sometimes sticky subs
by Jenny Ryltenius,Karolinska InstitutetCredit: CC0 Public DomainWhen you hear the words mucus and snot, you might think of colds, snails or drooling babies. But the runny, sometimes sticky subs
Science journalist Jon Cohen, physician-scientist Linda-Gail Bekker, and biochemist Wesley Sundquist describe the history of HIV/AIDS prevention and the unique mechanism that led lenacapavir to be named the 2024 Breakthrough of the Year.
Science journalist Jon Cohen, physician-scientist Linda-Gail Bekker, and biochemist Wesley Sundquist describe the history of HIV/AIDS prevention and the unique mechanism that led lenacapavir to be named the 2024 Breakthrough of the Year.